Supplementary Data S2 from SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
收藏数据链接：
官方服务：
资源简介：
AUC and EC50 values for PF-06939999 treated NSCLC cells
创建时间：
2022-01-01
